Clinical Trial Update: Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update on eltrombopag to enhance platelet engraftment in adult cord blood transplantation. The conditions include hematologic malignancy and bone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndrome
• Hematologic Malignancy

Drugs mentioned

• Promacta (eltrombopag)

Snippet

Sponsor: Rabin Medical Center | Conditions: Hematological Malignancy, Bone Marrow Failure Syndrome | Phase 2 | Status: UNKNOWN